4th PHARMACOVIGILANCE & DRUG SAFETY CONFERENCE

The 4th Pharmacovigilance & Drug Safety Conference is scheduled for April 29–30, 2025, at the Hotel Occidental Atenea Mar in Barcelona, Spain. This two-day event will delve into contemporary topics such as AI-driven pharmacovigilance, predictive analytics for adverse event detection, automation in drug safety reporting, and the role of real-world evidence in pharmacovigilance. The conference aims to provide a platform for impactful discussions, interactive roundtables, and keynote speeches from industry leaders, focusing on the evolving landscape of drug safety and regulatory challenges. Notable speakers include James Whitehead, Senior Director of Devices & Digital Safety at AstraZeneca; Pav Rishiraj, Director and Head of Pharmacovigilance (UK) at Ipsen; and Karthick Sukumaran, Technology Enablement Director for Intelligent Safety Automation at Roche. Their presentations will offer valuable insights into the integration of advanced technologies in pharmacovigilance and strategies to navigate the complex regulatory environment. Attendees will have the opportunity to engage with experts, participate in panel discussions, and explore innovative approaches to enhance drug safety practices.